BLOG: Hyper hopes for hyperopes

December 21, 2022

Print

MORE NEWS

November 22, 2023
VIDEO: Brimochol PF for presbyopia meets endpoints in phase 3 trial
>
Learn more about our latest developments

Visus Therapeutics, Inc.
2 Nickerson St. Ste 101
Seattle, WA 98109

© VISUS THERAPEUTICS 2021 ALL RIGHTS RESERVED
VISUS THERAPEUTICS and BRIMOCHOL are trademarks of Visus Therapeutics, Inc.